Women's Health Guide: PCOD, Uterine Fibroids & Preventive Gynaecological Care
"Evidence-based wellness insights on PCOD metabolic management, Pap smear cervical screening, and minimally invasive fibroid therapies."
Key Highlights at a Glance
- Annual Pap smear screening combined with HPV DNA co-testing prevents cervical cancer through precancerous lesion detection.
- Comprehensive metabolic and lifestyle management resolves PCOD irregular cycles and insulin resistance.
- Laparoscopic and hysteroscopic myomectomy removes uterine fibroids while preserving fertility and uterine integrity.
- Pelvic floor rehabilitation and bone density monitoring safeguard menopausal well-being.
1. Overview & Understanding the Condition
Women's physical and reproductive wellness evolves through distinct physiological milestones—from adolescence and reproductive years to perimenopause and beyond. Proactive gynaecological surveillance and modern minimally invasive interventions ensure optimal hormone balance, fertility preservation, and cancer prevention.
2. Common Symptoms & How It Is Diagnosed
Essential Preventive Health Priorities for Women:
Pap smear and high-risk HPV DNA testing starting at age 21
Early detection of polycystic ovarian morphology and endometrial hyperplasia
Evaluation for submucosal and intramural uterine leiomyomas
Screening for osteoporosis, vaginal atrophy, and post-menopausal bleeding
3. Treatment & Care Options
Minimally Invasive Gynaecological Procedures:
Daycare diagnostic and operative removal of endometrial polyps and submucosal fibroids without incisions
Precision surgical excision of large fibroids preserving the uterus for future pregnancy
Keyhole uterus removal with 24-hour discharge and minimal scar formation
4. Recovery & Daily Care Guidelines
Dr. Sharada Khaki (MRCOG UK) brings over 40 years of senior clinical excellence in high-risk obstetrics, infertility management, and advanced gynecological laparoscopy at Anviah Hospitals Gachibowli.
Frequently Asked Questions (FAQs)
Clinical guidance & patient care protocols for Obstetrics & Gynaecology
Women aged 21 to 29 should undergo a Pap smear every 3 years. Women aged 30 to 65 are advised to undergo combined Pap smear and HPV co-testing every 5 years (or Pap smear alone every 3 years).
Dr. Sharada Khaki
Verified ConsultantSenior Consultant Obstetrician & Gynecologist (MRCOG UK)
Department of Obstetrics & Gynaecology • Anviah Hospitals Gachibowli
This article is written and reviewed by our senior hospital doctors to ensure clear, accurate, and trustworthy health guidance for you and your family.
* Note: This guide is for general health awareness and does not replace personal consultation with a doctor.